SpectraCare Outpatient - Eufaula Alabama

SpectraCare Outpatient - Eufaula, AL

Spectracare Outpatient is a methadone and general addiction treatment center in Eufaula, AL, situated at 133 North Orange Avenue in the 36027 zip code. Spectracare Outpatient specializes in suboxone prescription. Some of the treatment approaches used by Spectracare Outpatient include substance use counseling, relapse prevention and trauma-related counseling. In addition, it provides group counseling, individual counseling and hepatitis education, counseling and support. Spectracare Outpatient caters its treatment program to women and men.

Address: 133 North Orange Avenue, Eufaula, AL 36027

1. Types of Care
2. Service Settings
3. Opioid Medications used in Treatment
4. Type of Alcohol Use Disorder Treatment
5. Type Of Treatment
6. Pharmacotherapies
7. Treatment Approaches
8. FacilityOwnership
9. License/Certification/Accreditation
10. Payment/Insurance/Funding Accepted
11. Payment Assistance Available
12. Special Programs/ Population Groups Supported
13. Assessment/Pre-treatment
14. Screening & Testing
15. Transitional Services
16. Ancillary Services
17. Counseling Services and Education
18. Tobacco/Screening Services
19. Facility Smoking Policy
20. Gender Accepted
21. Services for deaf

Additional details on SpectraCare Outpatient in Eufaula, AL:

Phone #: 800-951-4357

Benefits of Medication Assisted Treatment at SpectraCare Outpatient

Medication-Assisted Treatment (MAT) is an evidence-based approach to addiction recovery that combines behavioral therapy and counseling with the use of FDA-approved medications to treat substance use disorders (SUDs). MAT can be highly effective in helping individuals overcome addiction and achieve long-term recovery. Here are some of the benefits of Medication-Assisted Treatment for rehab at SpectraCare Outpatient:

1. Reduced Cravings: MAT medications can help reduce or eliminate cravings for drugs or alcohol, making it easier for individuals to abstain from substance use.

2. Withdrawal Symptom Management: MAT medications can alleviate the uncomfortable and sometimes dangerous withdrawal symptoms associated with substance cessation, helping individuals to remain in treatment.

3. Improved Treatment Retention: MAT has been shown to increase treatment retention rates, as individuals are more likely to stay engaged in therapy and counseling when they have medication support.

4. Decreased Risk of Relapse: MAT can significantly reduce the risk of relapse, allowing individuals to focus on building a stable and drug-free life.

5. Enhanced Quality of Life: By reducing drug cravings and withdrawal symptoms, MAT can improve an individual's overall quality of life, including their physical and mental health.

6. Lowered Mortality Rates: MAT has been associated with reduced mortality rates among individuals with opioid use disorders, as it can help prevent fatal overdoses.

7. Reduced Criminal Activity: Engaging in MAT can lead to a reduction in criminal activity associated with drug use, such as theft or drug-related offenses.

8. Improved Mental Health: MAT can help stabilize an individual's mental health, as substance use often exacerbates co-occurring mental health disorders.

9. Supportive Counseling: MAT programs typically include counseling and therapy, which can help individuals address the underlying issues contributing to their addiction and develop coping strategies.

10. Increased Functionality: Individuals in MAT programs often experience improved social and occupational functioning, as they can focus on rebuilding their lives without the constant interference of drug cravings.

11. Greater Success in Other Areas of Life: With the support of MAT, individuals can work on improving their relationships, education, employment, and housing situations, leading to a more stable and fulfilling life.

12. Potential for Long-Term Recovery: MAT can be a stepping stone to long-term recovery by providing the stability needed to make positive life changes and maintain sobriety.

It's important to note that the effectiveness of MAT may vary depending on the individual and the specific substance use disorder being treated. The choice of medication and the treatment plan should be tailored to the individual's needs and preferences, and it should be administered under the supervision of qualified staff at treatment centers, such as SpectraCare Outpatient, in conjunction with counseling and behavioral therapies. MAT is not a one-size-fits-all solution, but it can be a valuable tool in the comprehensive approach to addiction recovery.